echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Kelun Pharmaceutical's Tirofiban Hydrochloride and Sodium Chloride Injection Passed the Consistency Evaluation

    Kelun Pharmaceutical's Tirofiban Hydrochloride and Sodium Chloride Injection Passed the Consistency Evaluation

    • Last Update: 2021-04-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 4, Kelun Pharmaceutical issued an announcement stating that the "Drug Supplementary Application Approval Notice" for the chemical drug "Tirofiban Hydrochloride Sodium Chloride Injection" recently approved and issued by the National Medical Products Administration.


    Product specifications:

    100ml: tirofiban hydrochloride (calculated as C22H36N2O5S) 5mg and sodium chloride 0.


    250ml: tirofiban hydrochloride (calculated as C22H36N2O5S) 12.


    This product is mainly used for adult patients with non-ST-elevation acute coronary syndrome with ECG changes and/or myocardial enzyme elevation within 12 hours of the last chest pain onset, to prevent early myocardial infarction; and to plan direct PCI ( Percutaneous coronary intervention) in patients with acute myocardial infarction to reduce the occurrence of major cardiovascular events.


    Tirofiban is a platelet glycoprotein IIb/IIIa receptor antagonist.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.